Axsome Therapeutics (AXSM) Debt Ratio (2016 - 2026)

Axsome Therapeutics (AXSM) has 11 years of Debt Ratio data on file, last reported at 0.18 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 43.22% year-over-year to 0.18; the trailing twelve-month figure through Mar 2026 stood at 0.18 (down 43.22% YoY), and the FY2025 full-year result was 0.19, down 41.73% from the prior year.
• Debt Ratio fell to 0.18 in Q1 2026, from 0.19 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.56 in Q1 2022 to a low of 0.16 in Q3 2024.
• A 5-year average of 0.31 and a median of 0.31 in 2023 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio soared 91.24% in 2022 and sank 48.77% in 2024, its largest moves.
• Tracing AXSM's Debt Ratio over 5 years: stood at 0.3 in 2022, then increased by 3.79% to 0.31 in 2023, then climbed by 1.36% to 0.32 in 2024, then sank by 41.73% to 0.19 in 2025, then slipped by 2.4% to 0.18 in 2026.
• Business Quant data shows AXSM's Debt Ratio at 0.18 in Q1 2026, 0.19 in Q4 2025, and 0.19 in Q3 2025.